These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

727 related items for PubMed ID: 30515649

  • 1. Impact factors for the outcome of the first 131I radiotherapy in patients with papillary thyroid carcinoma after total thyroidectomy.
    Shangguan L, Fang S, Zhang P, Han S, Shen X, Geng Y, Luo D, Zhao C.
    Ann Nucl Med; 2019 Mar; 33(3):177-183. PubMed ID: 30515649
    [Abstract] [Full Text] [Related]

  • 2. Papillary thyroid carcinoma patients assessed to be at low or intermediary risk after primary treatment are at greater risk of long term recurrence if they are thyroglobulin antibody positive or do not have distinctly low thyroglobulin at initial assessment.
    Soyluk O, Boztepe H, Aral F, Alagol F, Özbey NC.
    Thyroid; 2011 Dec; 21(12):1301-8. PubMed ID: 22136265
    [Abstract] [Full Text] [Related]

  • 3. Pre-ablation stimulated thyroglobulin is a better predictor of recurrence in pathological N1a papillary thyroid carcinoma than the lymph node ratio.
    Chang YW, Kim HS, Jung SP, Kim HY, Lee JB, Bae JW, Son GS.
    Int J Clin Oncol; 2016 Oct; 21(5):862-868. PubMed ID: 26837274
    [Abstract] [Full Text] [Related]

  • 4. Preablative Stimulated Thyroglobulin Levels Can Predict Malignant Potential and Therapeutic Responsiveness of Subcentimeter-Sized, 18F-fluorodeoxyglucose-Avid Cervical Lymph Nodes in Patients With Papillary Thyroid Cancer.
    Kwon SY, Kim J, Jung SH, Chong A, Song HC, Bom HS, Min JJ.
    Clin Nucl Med; 2016 Jan; 41(1):e32-8. PubMed ID: 26164179
    [Abstract] [Full Text] [Related]

  • 5. Predictors of response to Radioactive Iodine Therapy in Intermediate and high risk patients with papillary thyroid carcinoma.
    Keshavarzi A, Alaei-Shahmiri F, Fallahi B, Emami Z, Malek M, Khamseh ME.
    BMC Endocr Disord; 2024 Jul 15; 24(1):112. PubMed ID: 39004697
    [Abstract] [Full Text] [Related]

  • 6. SIZE OF THE LARGEST METASTATIC FOCUS TO THE LYMPH NODE IS ASSOCIATED WITH INCOMPLETE RESPONSE OF PN1 PAPILLARY THYROID CARCINOMA.
    Deng Y, Zhu G, Ouyang W, Pan L, Feng H, Wu J, Chen P, Wang J, Xian J.
    Endocr Pract; 2019 Sep 15; 25(9):887-898. PubMed ID: 31170371
    [Abstract] [Full Text] [Related]

  • 7. Stimulating thyroglobulin to TSH ratio predict long-term efficacy of 131I therapy in patients with differentiated thyroid cancer after total thyroidectomy: a retrospective study.
    Yin X, Lu C, Sun D, Ji Y, Wang Y, Zheng H, Ma Z, Jia Q, Tan J, Zheng W.
    Endocrine; 2024 Jun 15; 84(3):1064-1071. PubMed ID: 38172344
    [Abstract] [Full Text] [Related]

  • 8. Clinicopathological features affecting the efficacy in 131I ablation therapy of papillary thyroid carcinoma with lymph node metastasis.
    Xu X, Li C, Yu X, Wang G, Guo Y, Ni H, Zhao W, Wang Y, Dong B.
    Front Endocrinol (Lausanne); 2024 Jun 15; 15():1382009. PubMed ID: 39086895
    [Abstract] [Full Text] [Related]

  • 9. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
    Rosario PW, Mineiro Filho AF, Lacerda RX, dos Santos DA, Calsolari MR.
    Thyroid; 2012 Feb 15; 22(2):113-6. PubMed ID: 22224815
    [Abstract] [Full Text] [Related]

  • 10. Value of post-therapeutic ¹³¹I scintigraphy in stimulated serum thyroglobulin-negative patients with metastatic differentiated thyroid carcinoma.
    Shen CT, Wei WJ, Qiu ZL, Song HJ, Luo QY.
    Endocrine; 2016 Feb 15; 51(2):283-90. PubMed ID: 26093847
    [Abstract] [Full Text] [Related]

  • 11. Low postoperative nonstimulated thyroglobulin as a criterion for the indication of low radioiodine activity in patients with papillary thyroid cancer of intermediate risk 'with higher risk features'.
    Rosario PW, Mourão GF, Calsolari MR.
    Clin Endocrinol (Oxf); 2016 Sep 15; 85(3):453-8. PubMed ID: 26801644
    [Abstract] [Full Text] [Related]

  • 12. Thyroglobulin levels and thyroglobulin/thyrotropin ratio could predict the success of the ablative/therapeutic 131I in the differentiated thyroid cancers.
    Trevizam PG, Tagliarini JV, Castilho EC, de Alencar Marques M, Kiy Y, Mazeto GMFS.
    Endocr Res; 2017 Feb 15; 42(1):42-48. PubMed ID: 27144920
    [Abstract] [Full Text] [Related]

  • 13. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
    Liu FH, Kuo SF, Hsueh C, Chao TC, Lin JD.
    J Surg Oncol; 2015 Aug 15; 112(2):149-54. PubMed ID: 26175314
    [Abstract] [Full Text] [Related]

  • 14. Video-Assisted Thyroidectomy for Papillary Thyroid Carcinoma: Oncologic Outcome in Patients with Follow-Up ≥ 10 Years.
    Bellantone R, Raffaelli M, De Crea C, Sessa L, Traini E, Princi P, Lombardi CP.
    World J Surg; 2018 Feb 15; 42(2):402-408. PubMed ID: 29238849
    [Abstract] [Full Text] [Related]

  • 15. Unexpected radioactive iodine accumulation on whole-body scan after I-131 ablation therapy for differentiated thyroid cancer.
    Iwano S, Ito S, Kamiya S, Ito R, Kato K, Naganawa S.
    Nagoya J Med Sci; 2020 May 15; 82(2):205-215. PubMed ID: 32581401
    [Abstract] [Full Text] [Related]

  • 16. Prognostic implication of thyroglobulin and quantified whole body scan after initial radioiodine therapy on early prediction of ablation and clinical response for the patients with differentiated thyroid cancer.
    Lim I, Kim SK, Hwang SS, Kim SW, Chung KW, Kang HS, Lee ES.
    Ann Nucl Med; 2012 Dec 15; 26(10):777-86. PubMed ID: 22869417
    [Abstract] [Full Text] [Related]

  • 17. Stimulated thyroglobulin and diagnostic 131-iodine whole-body scan as a predictor of distant metastasis and association with response to treatment in pediatric thyroid cancer patients.
    Garcia Alves-Junior PA, de Andrade Barreto MC, de Andrade FA, Bulzico DA, Corbo R, Vaisman F.
    Endocrine; 2024 Jun 15; 84(3):1081-1087. PubMed ID: 38296913
    [Abstract] [Full Text] [Related]

  • 18. Response to Therapy Assessment in Intermediate-Risk Thyroid Cancer Patients: Is Thyroglobulin Stimulation Required?
    Moreno I, Hirsch D, Duskin-Bitan H, Dicker-Cohen T, Shimon I, Robenshtok E.
    Thyroid; 2020 Jun 15; 30(6):863-870. PubMed ID: 31928205
    [Abstract] [Full Text] [Related]

  • 19. Early Post-operative Stimulated Serum Thyroglobulin: Role in Preventing Unnecessary Radioactive Iodine Treatment in Low to Intermediate Risk Papillary Thyroid Cancer.
    Sezer H, Yazıcı D, Terzioğlu T, Tezelman S, Canbaz HB, Yerlikaya A, Demirkol MO, Kapran Y, Çolakoğlu B, Çilingiroğlu EN, Alagöl F.
    Am Surg; 2023 Dec 15; 89(12):5996-6004. PubMed ID: 37309609
    [Abstract] [Full Text] [Related]

  • 20. Impact of routine unilateral central neck dissection on preablative and postablative stimulated thyroglobulin levels after total thyroidectomy in papillary thyroid carcinoma.
    Lang BH, Wong KP, Wan KY, Lo CY.
    Ann Surg Oncol; 2012 Jan 15; 19(1):60-7. PubMed ID: 21681379
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.